Source-linked AI summary
Learning Counterfactual Representations for Estimating Individual Dose-Response Curves
Patrick Schwab, Lorenz Linhardt, Stefan Bauer, Joachim M. Buhmann, Walter Karlen
TL;DR
Observational counterfactual methods have focused on average dose-response curves or two treatments without dosage parameters, despite the need to estimate individual responses. The paper develops neural-network methods for multiple treatments with continuous dosages and introduces supporting evaluation resources. Across benchmarks, DRNets outperform existing state-of-the-art methods, while performance depends on model structure and dosage resolution.
Problem
Existing counterfactual methods focus on average dose-response curves or two treatments without dosage parameters, limiting individual dose-response estimation from observational data.
Method
The paper trains neural networks for counterfactual inference with any number of treatments and continuous dosages, using regularisation, model architectures, metrics, selection criteria, and benchmarks.
Results
DRNets outperform existing state-of-the-art methods across several benchmarks, and performance improves with dosage resolution but requires more computation.
Takeaways & Limitations
Model structure is paramount for learning counterfactual dose-response representations, and dosage resolution involves a performance–computation trade-off.
Takeaways & Limitations
The approach assumes unconfoundedness, requiring reasonable certainty that the available covariates contain the most relevant variables.
Abstract
from arXiv · showhide
Estimating what would be an individual's potential response to varying levels of exposure to a treatment is of high practical relevance for several important fields, such as healthcare, economics and public policy. However, existing methods for learning to estimate counterfactual outcomes from observational data are either focused on estimating average dose-response curves, or limited to settings with only two treatments that do not have an associated dosage parameter. Here, we present a novel machine-learning approach towards learning counterfactual representations for estimating individual dose-response curves for any number of treatments with continuous dosage parameters with neural networks. Building on the established potential outcomes framework, we introduce performance metrics, model selection criteria, model architectures, and open benchmarks for estimating individual dose-response curves. Our experiments show that the methods developed in this work set a new state-of-the-art in estimating individual dose-response.
1 Introduction
Estimating individual dose-response curves from observational data is difficult because counterfactual outcomes are unobserved and treatment assignment can be biased. The paper addresses this gap with neural-network methods, evaluation tools, and benchmarks for multiple treatments with continuous dosages.
- Counterfactual dose-response estimation asks which treatment and dosage would produce better outcomes for a particular patient.
- Observational data reveal only factual outcomes, leaving alternative treatment outcomes unobserved.
- The proposed neural-network methodology supports any number of treatments with continuous dosage parameters.
- The paper introduces performance metrics, model-selection criteria, model architectures, and open benchmarks for individual dose-response curves.
- The experiments report a new state-of-the-art for inferring individual dose-response curves from observational data.
2 Related Work
Prior causal-inference methods largely address two treatments without dosage parameters, while this work extends neural-network counterfactual inference to multiple treatments with continuous dosages. The paper also targets individual differences that population-average dose-response estimates do not capture.
- Most existing methods focus on two treatment options without associated dosage parameters.
- The generalised propensity score extends propensity scores to treatments with continuous dosages.
- The paper presents the first neural-network approach for individual dose-response curves across multiple treatments with continuous dosage parameters.
- The approach extends regularisation schemes for counterfactual inference to address treatment-assignment bias in observational data.
- Individual dose-response estimation is motivated by documented differences between people that population-average dose-response curves overlook.
3 Methodology
The methodology formulates individual dose-response estimation across multiple treatments and continuous dosages, combining counterfactual metrics, model-selection procedures, hierarchical neural architectures, and regularisation under unconfoundedness assumptions.
- Problem formulation: The task estimates each sample’s potential outcomes across all treatment options and dosage values, using factual observational outcomes to learn individual dose-response curves.Treatments may number two or more, with treatment-specific dosage ranges [a_t, b_t].
- Assumptions: The approach assumes unconfoundedness through conditional independence, common support, and stable unit treatment value.These assumptions concern treatment assignment, observability of treatment options, and interference between units.
- Metrics: The framework evaluates curve recovery, treatment-specific dosage selection, and overall treatment-policy selection using MISE, DPE, and PE.MISE covers the full dosage range, DPE assesses estimated versus true optimal dosage, and PE assesses the chosen treatment and dosage jointly.
- Model selection: Model selection uses a nearest-neighbour approximation of MISE on held-out factual data because true counterfactual outcomes are unavailable.The approximation substitutes a sample’s true dose-response with outcomes from an observed factual nearest neighbour at dosage points.
- Model architecture: DRNet uses shared base layers, treatment-specific layers, and dosage-stratum heads to preserve treatment and dosage information while sharing representations.Each head predicts outcomes within a dosage partition, while the hierarchy shares information across samples, treatments, and dosage strata.
- Regularisation: DRNets can incorporate distribution matching, propensity dropout, and matching-based regularisation to address treatment-assignment bias in observational data.These schemes were extended from counterfactual settings that were not originally developed for dose-response estimation.
4 Experiments
The experiments use three semi-synthetic benchmarks and compare DRNet with baselines, ablations, and state-of-the-art methods under systematically controlled evaluation settings. They examine comparative performance, dosage-stratum choices, and treatment-assignment bias.
- Research questions: The experiments ask how the proposed approach compares with existing methods, how the number of dosage strata affects performance, and how treatment-assignment bias changes estimator performance.These questions define the main comparative and sensitivity analyses.
- Datasets: Experiments use three semi-synthetic datasets spanning different outcome and treatment-assignment functions, sample sizes, feature counts, and numbers of treatments.Each dataset is randomly divided into training, validation, and test sets using 63%, 27%, and 10% splits.
- Datasets: The benchmarks include News, MVICU, and TCGA, covering news articles, intensive-care ventilation responses, and cancer-treatment outcomes.TCGA includes three treatment options: medication, chemotherapy, and surgery.
- Dosage-strata analysis: Higher numbers of dosage strata generally improve estimation performance but trade computational performance against increased dosage resolution.The dosage-strata analysis is conducted on MVICU with other hyperparameters held equal.
- Models: The evaluation compares DRNet, ablations, kNN, BART, CF, GANITE, TARNET, and GPS, including several DRNet regularisation strategies.Regularisation variants include Wasserstein matching, propensity dropout, and batch or full-dataset matching.
- Evaluation protocol: Hyperparameter searches use the same number of random configurations and the same random seed across models for each benchmark.The search uses five runs on TCGA and ten on the other benchmarks.
5 Results and Discussion
DRNets outperformed existing methods across multiple benchmarks and treatment-assignment bias levels, while dosage-strata resolution improved estimation at increased computational cost. The analysis also identifies unconfoundedness as a key assumption for observational causal inference.
- Counterfactual Inference: DRNets outperformed all existing state-of-the-art methods in MISE across the News-2/4/8/16, MVICU, and TCGA benchmarks.Additional regularisation improved vanilla DRNets on News benchmarks but performed similarly on MVICU and TCGA.
- Counterfactual Inference: The hierarchical dosage subdivision in DRNets was effective, and model structure was important for learning counterfactual representations.DRNet improved on both TARNET and the MLP baseline by a large margin across all datasets.
- Number of Dosage Strata E: Higher numbers of dosage strata generally improved estimation performance by increasing dosage-partition resolution but consistently increased training and prediction time.This establishes a trade-off between resolution and computational performance.
- Treatment Assignment Bias: DRNet outperformed TARNET, MLP, and GPS across the evaluated treatment-assignment bias range and remained more robust as bias increased.The comparison varied κ from 5 to 20 on the News-2 test set.
- Limitations: The observational-data approach assumes unconfoundedness, requiring reasonable certainty that the covariate set contains the most relevant variables.Assessing this condition can be difficult when prior knowledge of the underlying causal process is limited.
6 Conclusion
The paper presents a deep-learning approach for estimating individual dose-response curves across multiple treatments with continuous dosage parameters from observational data. Experiments show that DRNets outperform existing methods, while revealing a resolution–computation trade-off.
- Conclusion: The paper estimates individual dose-response curves for multiple treatments with continuous dosage parameters using observational data.It extends regularisation strategies and introduces metrics, model-selection criteria, architectures, and open benchmarks for this setting.
- Conclusion: DRNets significantly outperform existing state-of-the-art methods across several benchmarks for inferring individual dose-response curves.The experiments also identify model structure as paramount for learning neural counterfactual representations.
- Conclusion: Increasing DRNet resolution through more dosage strata improves estimation performance but increases computational cost.The conclusion characterizes this as a trade-off between model resolution and computational performance.
Supplementary Material for: Learning Counterfactual Representations for Estimating Individual Dose-Response Curves
The supplied supplementary-material passage contains only the authors’ names and does not provide substantive methodological, experimental, or interpretive content.
- Supplementary Material: The supplementary-material passage lists Patrick Schwab, Lorenz Linhardt, Stefan Bauer, Joachim M. Buhmann, and Walter Karlen.No supplementary methods, results, or conclusions are included in the passage.
A Treatment Assignment Bias Regularisation
The treatment-assignment-bias regularisation experiments compare four strategies adapted to parametric treatments. These include distribution matching, propensity dropout, and matching at dataset or batch level.
- Regularisation Strategies: The study evaluates four regularisation strategies for treatment-assignment bias in DRNets.They are Wasserstein distribution matching, propensity dropout, whole-dataset matching, and batch-level matching.
- Regularisation Strategies: Because the strategies were originally developed for other treatment settings, the study implements naive extensions for parametric treatment options.The extensions target settings with dosage parameters.
B Hyperparameters
The experiments used standardized, reproducible hyperparameter selection, while GPS additionally used dimensionality reduction to manage computation.
- Hyperparameter ranges: Table S1 lists the hyperparameter ranges used in the experiments.
- Computational preprocessing: GPS experiments used PCA with 16 principal components when covariate dimensionality exceeded 200.This preprocessing was introduced to reduce GPS computational requirements.
C Computing Infrastructure
The experiments ran on compute nodes equipped with Intel i5 and Xeon CPUs.
- Computing infrastructure: The reported experiments used computing infrastructure with Intel i5 and Xeon CPUs.
D Dosage Policy Error and Policy Error Results
DRNets generally achieved the strongest Dosage Policy Error and Policy Error results across the reported benchmarks, with one Policy Error exception on News-8.
- Dosage Policy Error: DRNets outperformed all existing state-of-the-art methods on Dosage Policy Error across the reported benchmarks.Dosage Policy Error results are reported in Table S2, whose caption specifies mean ± standard deviation over five repeat runs.
- Policy Error: DRNets outperformed existing state-of-the-art methods on Policy Error except on News-8, where GPS achieved the best result.The News-8 exception left DRNets with the second-best Policy Error result.